Skip to main content
. 2019 Jul 20;1:13–20. doi: 10.1016/j.prdoa.2019.07.003

Table 1.

Descriptive statistics of study subjects and correlations between study variables.

Study variable Mean ± standard deviation
Pearson correlation coefficient and P-valueb
PPMI diagnostic category
Study variable
Healthy controls
n = 198
F = 71
Asymptomatic genetic Parkinson's disease
n = 310
F = 187
Symptomatic genetic Parkinson's disease
n = 220
F = 113
Sporadic Parkinson's disease
n = 491
F = 169
Possible prodromal Parkinson's disease
n = 61
F = 13
UPSIT
n = 1280
HVLT
n = 1280
MoCA
n = 1276
Visu-Exec
n = 1280
Delayed recall
n = 1279
Attention
n = 1280
Age
n = 1280
UPSIT (40)a 34.0 ± 4.8 33.0 ± 4.9 21.5 ± 8.9 23.4 ± 8.7 17.2 ± 6.6
HVLT (30)a 26.0 ± 4.5 26.5 ± 5.2 24.0 ± 5.6 24.4 ± 4.9 22.0 ± 5.3 0.281
1.2 × 10−24
MoCA (30)a 28.2 ± 1.1 26.7 ± 2.3 25.9 ± 3.5 27.1 ± 2.3 26.2 ± 3.6 0.182
6.2 × 10−11
0.449
1.9 × 10−64
Visu-Exec (5)a 4.66 ± 0.59 4.35 ± 0.88 4.22 ± 0.99 4.49 ± 0.80 4.03 ± 1.21 0.132
2.2 × 10−6
0.195
1.9 × 10−12
0.353
7.8 × 10−39
Delayed-Recall (5)a 3.88 ± 0.98 3.04 ± 1.57 3.22 ± 1.48 3.35 ± 1.41 3.31 ± 1.43 0.088
1.6 × 10−3
0.243
1.1 × 10−18
0.468
2.5 × 10−70
0.185
2.8 × 10−11
Attention (6)a 5.89 ± 0.32 5.72 ± 0.56 5.49 ± 0.90 5.76 ± 0.59 5.39 ± 1.37 0.104
2.1 × 10−4
0.171
7.5 × 10−10
0.395
5.5 × 10−49
0.323
2.0 × 10−32
0.227
2.1 × 10−16
Age 67.4 ± 11.0 63.9 ± 7.4 64.4 ± 10.2 67.8 ± 9.8 72.8 ± 6.1 0.190
7.4 × 10−12
0.258
6.4 × 10−21
0.160
8.3 × 10−9
0.090
1.3 × 10−3
0.088
1.6 × 10−3
0.011
6.9 × 10−1
a

Maximum score or subscore on assessment.

b

Correlations calculated with missing-value cases excluded pairwise, bold indicates significance at the 0.01 level (two-tailed). UPSIT: University of Pennsylvania Smell Identification Test. HVLT: Hopkins Verbal Learning Test. MoCA: Montreal Cognitive Assessment Test. Visu-Exec: MoCA subscore for visuospatial and executive function. Delayed-Recall: MoCA subscore for delayed recall. PPMI-defined diagnostic groups: Asymptomatic-genetic-Parkinson's-disease subjects have a mutation, or are a first-degree relative of an individual having a mutation, in LRRK2, SNCA, or GBA; Symptomatic-genetic-Parkinson's-disease subjects have a mutation in LRRK2, SNCA, or GBA; Possible-prodromal-Parkinson's-disease subjects have REM-behavior sleep disorder and/or hyposmia.